Aspirin can reduce the risk of colon cancer and the recurrence of colorectal adenoma, but only at doses high enough to incur risk of GI complications, a new study shows (Gastroenterology.

An analysis of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial has shown that patients with ST-segment-elevation MI (STEMI) undergoing ...

A new clinical trial tested low-dose aspirin in patients with colon and rectal cancer, also referred to as colorectal cancer. The researchers wanted to see if taking aspirin daily could help prevent ...

Topline data from High-Dose Aspirin Trail anticipated early in 3Q with the potential to support an accelerated approval, subject to FDA feedback HUMACAO, PR and NEW YORK, NY / ACCESS Newswire / May 20 ...

Physicians should no longer routinely prescribe a daily regimen of low-dose aspirin for most patients at high risk of their first heart attack or stroke, according to draft guidelines the U.S.

Please provide your email address to receive an email when new articles are posted on . The proportion of patients receiving low-dose aspirin increased from 7.65% in 2012 to 55.29% in 2022. A low-dose ...

Enrollment Completed on Schedule; Topline Results Expected Mid Q3 2025 ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the ...

HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery ...